An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocolRachael Sagar, Cecilia Götherström, Anna L. David et al.|BMJ Open|2024Cited by 20
Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and NewbornDerek de Winter, Ángel Guillermo Alcázar Grisi, E. J. T. Verweij et al.|JAMA Network Open|2025Cited by 14